Cheryl Gault, Chief Operating Officer at Rapport Therapeutics, Inc. (RAPP), sold 20,000 shares at $28.04 ($564K) on 2026-03-30, disclosed to the SEC on 2026-03-31.
Scheduled sale ($564k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.04 | 7,161 | $201K | 35.6% |
| 2 | $28.04 | 7,161 | $201K | 35.6% |
| 3 | $28.55 | 2,839 | $81K | 14.4% |
| 4 | $28.55 | 2,839 | $81K | 14.4% |
| Total | $28.19 avg | 20,000 | $564K | 100% |
| Filing → |
| RAPP | SELL | 2025-12-01 | $151K | — | Filing → |
| RAPP | SELL | 2025-09-10 | $192K | — | Filing → |